Paul Offit Chief of the Division of Infectious Diseases, Children's Hospital of Philadelphia Mr. Offit appears to be the pharmaceutical industry�s go to Doctor to speak to the press about the safety of the current vaccine program. He is also the patent holder for the new rotavirus vaccine, recently added to the Immunization Schedule, and a past member of the ACIP (See #1). Among his many outrageous statements, Mr. Offit wrote in the journal of Pediatrics that a child�s immune system could handle 10,000 vaccines: "A more practical way to determine the diversity of the immune response would be to estimate the number of vaccines to which a child could respond at one time...then each infant would have the theoretical capacity to respond to about 10,000 vaccines at any one time." Regarding Thimerosal in vaccines: "In some instances I think full disclosure can be harmful. Is it safe to say there is zero risk with thimerosal, when it is remotely possible that one child would get sick? Well, since we say that mercury is a neurotoxin, we have to do everything we can to get rid of it. But I would argue that removing thimerosal didn't make vaccines safer -- it only made them perceptibly safer." On potential conflicts of interest as a vaccine patent-holder: "I am a co-holder of a patent for a (rotavirus) vaccine. If this vaccine were to become a routinely recommended vaccine, I would make money off of that. When I review safety data, am I biased? That answer is really easy: absolutely not." Speaking to a journalist: "You did more harm than good in sort of quote/unquote allowing the parent to be fully informed [regarding the presence of mercury in vaccines]. There�s no politically correct way to say this, but being fully informed is not always the best thing. You can take that out of context and make me look like a jerk, but you know what I�m saying." |
No comments:
Post a Comment